首页> 外国专利> DELETED IGE-DEPENDENT HISTAMINE RELEASING FACTOR HAVING HISTAMINE SECRETION FUNCTION, HRF BINDING PEPTIDE AND USE THEREOF

DELETED IGE-DEPENDENT HISTAMINE RELEASING FACTOR HAVING HISTAMINE SECRETION FUNCTION, HRF BINDING PEPTIDE AND USE THEREOF

机译:具有组氨酸分泌功能,与HRF结合的肽的IGE依赖性组氨酸释放因子及其用途

摘要

PPROBLEM TO BE SOLVED: To provide an IgE-dependent histamine releasing factor (HRF) and a peptide bonding to the factor. PSOLUTION: The invention provides a deleted HRF capable of forming a dimer containing an amino acid sequence expressed by sequence No.3, a gene encoding the deleted HRF, and a new HRF-binding peptide capable of suppressing the activity of HRF. Since the deleted HRF capable of forming the dimer enables the secretion of histamine and IL-8 in a cell, it can be used for the development of a medicine to suppress the allergy by HRF and a kit for detecting the HRF in the serum of an allergy patient. The new HRF-binding peptide is bonded to HRF to inhibit the action and, accordingly, it is effective for the prevention and treatment of allergic diseases of animals such as asthma and rhinitis, and malaria. PCOPYRIGHT: (C)2006,JPO&NCIPI
机译:

要解决的问题:提供依赖IgE的组胺释放因子(HRF)和与该因子结合的肽。解决方案:本发明提供了一种缺失的HRF,其能够形成包含由序列号3表示的氨基酸序列的二聚体,编码缺失的HRF的基因以及能够抑制HRF活性的新的HRF结合肽。由于缺失的能够形成二聚体的HRF能够在细胞中分泌组胺和IL-8,因此可以用于开发抑制HRF过敏的药物和用于检测HRF血清中HRF的试剂盒。过敏患者。新的HRF结合肽与HRF结合以抑制该作用,因此,对于预防和治疗动物的过敏性疾病如哮喘和鼻炎以及疟疾有效。

版权:(C)2006,JPO&NCIPI

著录项

  • 公开/公告号JP2006212029A

    专利类型

  • 公开/公告日2006-08-17

    原文格式PDF

  • 申请/专利权人 EWHA UNIV-INDUSTRY COLLABORATION FOUNDATION;

    申请/专利号JP20060015614

  • 发明设计人 LEE KYUNGLIM;KIM MIYOUNG;

    申请日2006-01-24

  • 分类号C12N15/09;C07K14/47;C07K16/18;C07K19;C12N1/21;A61K38;A61P37/08;A61P33/06;G01N33/50;G01N33/15;G01N33/53;G01N33/566;

  • 国家 JP

  • 入库时间 2022-08-21 21:56:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号